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Mutations in the genes coding for connexin 26 (Cx26), connexin 30 (Cx30), and connexin 31 (Cx31) are the main
cause of autosomal recessive nonsyndromic sensorineural hearing loss (AR-NSNHL). The 35delG mutation is the
most frequent in the majority of Caucasian populations and may account for up to 70% of all GJB2 mutations. As
a large number of affected individuals (10%–40%) with GJB2 mutations carry only one mutant allele, it has been
postulated that the presence of additional mutations in the GJB6 gene (Cx30) explains the deafness condition
found in these patients. In the present study, we screened the c.35delG mutation in *600 unrelated Brazilian
patients, with moderate to profound AR-NSNHL. Other point mutations in the coding region of the GJB2 gene
were screened by sequencing analysis as well as the IVS 1 + 1 G > A splice site mutation in the same gene. Digenic
mutations including large deletions and duplications were investigated in the Cx26, 30, and 31 genes in
monoallelic individuals for mutations in the GJB2 gene. Large deletions and duplications were assessed by
multiplex ligation-dependent probe amplification. We found 46 patients with mutations in only one GJB2 allele.
Different pathogenic mutations associated with c.35delG were found in 13 patients. Two patients were identified
with digenic heterozygous mutations. Our findings contributed to more accurate diagnosis and more appro-
priate genetic counseling in 28% of patients studied (13/46).
Introduction
Hearing loss is the most prevalent form of sensory im-pairment in humans. In developed countries, genetic
inheritance is responsible for > 60% of the cases (Morton et al.,
2006). Despite the enormous heterogeneity of genetic hearing
loss, up to 50% of autosomal recessive nonsyndromic senso-
rineural hearing loss (AR-NSNHL) is associated with muta-
tions in the locus DFNB1 on chromosome 13q12 (Kenneson
et al., 2002). This locus contains the GJB2 and GJB6 genes,
which code for the gap junction (GJ) proteins connexin 26
(Cx26) and connexin 30 (Cx30), respectively. GJ proteins are
transmembrane proteins responsible for the maintenance of
extracellular electrical potential. Connexins have four trans-
membrane segments (TM1–4), two extracellular loops (EC1
and EC2), a cytoplasmic loop, an N-terminal helix, and a C-
terminal segment. Six monomers of connexin assemble to
form a hemichannel (connexon), which docks with another
connexon of an adjacent cell to form an intercellular GJ
channel (Kumar and Gilula, 1996). Different connexins, in-
cluding Cx26, Cx30, and Cx31 (GJB3 gene), participate in the
complex GJ networks, which play a key role in potassium
homeostasis, essential for sound transduction in the cochlea
(Steel et al., 2001).
To date, mutations in the GJB2, GJB6, and GJB3 genes are
known to result in hearing impairment. Among the mutations
described in GJB2, the c.35delG is the most frequent and ac-
counts for up to 70% of all GJB2 mutations (Seeman et al.,
2004). However, in different populations, 10%–40% of the
patients with AR-NSNHL carry only one pathogenic muta-
tion in the GJB2 gene, which causes a problem in molecular
diagnostic and genetic counseling.
Many studies have shown that additional screening for
deletions in GJB6 gene (Cx30) provide an explanation for the
deafness in as many as 30%–70% of affected GJB2 heterozy-
gotes (del Castillo et al., 2003, 2005). Two deletions of 309 and
232 kb, del(GJB6-D13S1830) and del(GJB6-D13S1854), re-
spectively, were found segregating with hearing loss in pa-
tients carrying monoallelic GJB2 mutation (del Castillo et al.,
2005). Significant differences in the frequency of these
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deletions among probands with AR-NSNHL have been re-
ported in different populations. In particular, the deletion
del(GJB6-D13S1830) is the second most common reason for
deafness in the Spanish population (del Castillo et al., 2003),
whereas in other countries it has been considered rare (Frei
et al., 2004; Seeman et al., 2005).
The high prevalence of patients carrying only one mutant
allele in GJB2 with lack of the deletions del(GJB6-D13S1830)
and del(GJB6-D13S1854) in some populations strongly sug-
gests that additional mutations within the DFNB1 locus and
elsewhere involved in epistatic interactions with GJB2 remain
to be identified.
In fact, Wilch et al. (2006) identified a novel 131.4-kb dele-
tion, distant from the transcriptional start sites of both GJB2
and GJB6, which segregates as a DFNB1 allele in the extended
family and also segregates with reduced expression of either
GJB2 or GJB6 mRNA in four family members.
Further, direct interaction of Cx26 with Cx31 (GJB3) has
been shown to result in hearing loss in digenic heterozygotes.
GJB3 mutations occurring in heterozygosity with the GJB2
mutations have been identified in three unrelated Chinese
families (Liu et al., 2009). Variations in the GJB3 gene have
been also linked to nonsyndromic deafness in Brazilian pa-
tients (Alexandrino et al., 2004). Mutations in the GJB3 gene
were initially linked to nonsyndromic autosomal dominant
hearing loss (Xia et al., 1998) and, subsequently, with auto-
somal recessive deafness (Liu et al., 2000).
The aim of this study was to explain the etiology of deaf-
ness in heterozygous GJB2 patients with AR-NSNHL. The
identification of deletions and duplications in GJB2, GJB3, or
GJB6 genes could contribute to more accurate diagnosis and
more appropriate genetic counseling.
Materials and Methods
Patients
Six hundred unrelated Brazilian patients with moderate to
profound AR-NSNHL were screened for 35delG mutation.
Thirty-two patients were homozygous for 35delG mutation.
These patients were ruled out for subsequent analysis per-
formed. Initially, we detected 40 heterozygous 35delG pa-
tients. After sequencing analysis of the coding region and part
of exon 1 and the flanking donor splicing site of the GJB2 gene,
six other patients with additional mutations [p.M34T (1),
p.K168R (3), p.V37I (1) and IVS 1 + 1 G > A (1)] in only one
GJB2 allele were included.
The majority of patients studied were Caucasian; however,
the Brazilian population composition is one of the most het-
erogeneous in the world with interethnic crosses between
peoples from three continents: Amerindians, Europeans, and
Africans (Parra et al., 2003).
The protocol was approved by the Ethics Committee of the
State University of Campinas, and a written informed consent
was obtained from the tested patients or their parents. Syn-
dromic hearing impairment and other nonhereditary causes
were excluded by medical history, physical examination, and
audiological testing.
Methods
Molecular analysis. DNA samples were extracted from
peripheral blood by a standard phenol–chloroform method
(Sambrook et al., 1989). All patients were previously investi-
gated for c.35delG mutation by allele-specific polymerase
chain reaction (PCR) using primers and conditions as pub-
lished elsewhere (Scott et al., 1998).
The coding region (exon 2) of GJB2 gene was amplified by
PCR and subsequent sequencing analysis was performed. The
results were compared with the wild-type GJB2 sequence
(GenBank Accession No. GI62999485) to identify the mutations.
Additionally, to detect IVS 1 + 1 G > A mutation, the exon 1
and flanking donor splicing site were amplified with primers
Cx26Ex1 F (5¢-TCC GTA ACT TTC CCA GTC TCC GAG GGA
AGA GG-3¢) and Cx26Ex1 R (5¢-CCC AAG GAC GTG TGT
TGG TCC AGC CCC-3¢), previously described (Denoyelle
et al. 1999). The amplified segments were digested with a re-
striction enzyme HphI according to the manufacturer’s re-
commended digestion conditions. The PCR products were
also sequenced using the same primers and the Big Dye Ter-
minator Ver.3 kit (Applied Biosystems) and subsequently
analyzed on an ABI PRISM 3700 DNA analyzer (Applied
Biosystems) to confirm the presence of the mutation.
To screen the del(GJB6-D13S1830) and del(GJB6-D13S1854)
mutations, we followed the procedure described by del Cas-
tillo et al. (2005).
The deletion del(chr13:19,837,344–19,968,698) of 131.4 kb,
whose proximal breakpoint lies > 100 kb upstream of the tran-
scriptional start sites of GJB2 and GJB6, was also screened in all
samples by PCR as previously described by Wilch et al. (2010).
Multiplex ligation-dependent probe amplification. Large
deletions or duplications in the GJB2, GJB3, and GJB6 genes
were screened in all samples by the multiplex ligation-
dependent probe amplification (MLPA) method, using the
MLPA P163-B1GJB kit (Microbiology Research Centre-
Holland). All reactions were carried out according to the
manufacturer’s protocol. DNA samples from five healthy in-
dividuals were used as normal controls and one sample from
a del(GJB6-D13S1830) homozygous deaf patient was used as a
positive control. Fragment analysis was performed on an ABI
310 Genetic Analyzer and results were examined using Gen-
escan and Genotyper software (Applied Biosystems). Peak
areas of the amplicons representing the respective probe were
exported to a Microsoft Excel spreadsheet and calculations
were performed according to the method described by Taylor
et al. (2003).
Results
We investigated the presence of additional mutations af-
fecting other alleles in a total of 46 GJB2 heterozygous patients
with nonsyndromic sensorial deafness. Pathogenic mutations
associated with 35delG were found in 13 patients. Therefore,
the complete genotype was established in 28% of them (13/
46). The genotypes identified are shown in Table 1.
Eight pathogenic sequence variations, other than 35delG,
could be identified by direct sequencing of the GJB2 gene
(Table 2). Among them, the IVS 1 + 1 G > A splice site mutation
in the noncoding region was identified in two patients
with profound deafness in compound heterozygosity with
35delG. The segregation of each allele could be confirmed
in the parents. Concerning the GJB6 gene, the deletions
del(GJB6-D13S1830) and del(GJB6-D13S1854) were found in
two heterozygous c.35delG patients (2/46; 4.3%). The novel
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DFNB1 allele, del(chr13:19,837,344–19,968,698), was not
identified in any of the patients studied.
The p.K168R, a variant of unknown significance, was the
second most frequent mutation found (Table 1). Thus, we also
carried out p. K168R mutation screening in 115 (230 tested
alleles) normal-hearing Brazilian controls. The mutation was
not found in any of them.
Multiplex ligation-dependent probe amplification
MLPA screening for large deletions and duplications in the
patients, who carried monoallelic GJB2 mutation, did not reveal
any copy number changes in Cx31 (GJB3). However, this
method detected the c.35delG mutation in all 40 heterozygous
patients and the IVS 1 + 1 G > A mutation in 3 patients. The
MLPA method was also able to detect the presence of the
del(GJB6-D13S1830) deletion in a homozygous positive control.
The del(GJB6-D13S1854) and del(GJB6-D13S1830) in heterozy-
gosis, associated with c.35delG, were detected in two patients
(2/46; 4.3%). Average value of peak areas of amplicons (com-
puted in comparison to controls) corresponding to Cx30 (GJB6)
showed a 50% reduction in the heterozygous samples.
Discussion
The study of genetic causes of deafness has significantly
advanced in recent years. However, there are still some dif-
ficulties that should be overcome. The main obstacle to mo-
lecular diagnosis is the genetic heterogeneity of hearing loss.
Many genes are involved in the hearing physiology and little
is known about the individual contribution of each gene and
its mutations. Moreover, the large number of deaf patients
carrying only one GJB2 mutant allele further complicates the
genetic evaluation and counseling. This may be caused by the
technical limitations of the methods used for mutation anal-
ysis or by the presence of mutations in regulatory elements
that remain to be identified and mutations in other genes
whose protein products are involved in interaction with Cx26.
To address this question, we investigated large deletions
and duplications in three connexin genes simultaneously,
GJB2, GJB3, and GJB6, in monoallelic GJB2 deaf Brazilian in-
dividuals, using MLPA analysis.
Screening for deletions in the GJB6 gene allowed us to
clarify the genetic cause of hearing loss in 4.4% of the GJB2
heterozygous patients. The deletion del(chr13:19,837,344–
19,968,698), described by Wilch et al., was not found in pa-
tients analyzed, which may indicate that this deletion is not
frequent among Brazilian deaf individuals. In a previous
study, this deletion has not been identified among 528 indi-
viduals with monoallelic GJB2/GJB6 mutation from the Uni-
ted States, Brazil, Iran, and several European countries (Wilch
et al., 2010).
Although the screening of del(GJB6-D13S1830) and
del(GJB6-D13S1854) mutations may explain deafness in up to
3%–30% of Brazilian GJB2 heterozygous patients (Oliveira
et al., 2004; Piatto et al., 2004; del Castillo et al., 2005), it is clear
that other mutations within or outside the DFNB1 locus may
be involved in epistatic interactions with GJB2, significantly
contributing to AR-NSNHL.
In the present study, we also investigated the presence of a
second point mutation in the GJB2 gene in 35delG heterozy-
gous patients by sequencing analysis. We have detected eight
already described mutations associated with 35delG (com-
pound heterozygote). The p.W24X and IVS1 1 + 1 G > A are
truncating mutations, which result in no formation of the GJ
in the cell membrane. The p.M34T, p.V37I, p.L90P, p.V95M,
p.R184W, and p.R184P missense mutations found in the GJB2
gene interfere either on the connexons alignment or in the GJ
permeability, abolishing normal intercellular communica-
tions.
The IVS1 1 + 1 G > A splice site mutation was found in
three patients. In two of them, IVS1 1 + 1 G > A was detected
associated with the c.35delG mutation. This mutation, al-
though initially considered rare, has been found in several
populations (Seeman et al., 2006; Bajaj et al., 2008; Gravina
et al., 2010). The IVS1 1 + 1 G > A mutation corresponds to
c.-3170 G > A relative to the AUG translation-initiating codon
(GenBank Accession No. U43932). Functional studies of the
IVS 1 + 1 G > A mutation have revealed a disruptive splicing,
yielding no detectable mRNA (Shahin et al., 2002).
Previously, we documented the presence of the IVS 1 + 1
G > A mutation in c.35delG heterozygous Brazilian patients
Table 1. Genotypes Detected in Monoallelic Patients
Gene Genotype No. of patients
Cx26 c.35delG/wt 27




















Cx26 c.-3170G > A





c.71G > A p.W24X
(truncating)
2.2% (1/46)
c.101T > C p.M34T 2.2% (1/46)
c.109G > A p.V37I 2.2% (1/46)
c.269T > C p.L90P 4.3% (2/46)
c.283G > A p.V95M 4.3% (2/46)
c.550C > T p.R184W 2.2% (1/46)
c.551C > G p.R184P 2.2% (1/46)
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with hearing impairment (da Silva-Costa et al., 2009). Our
results may indicate that IVS1 1 + 1 G > A is not rare among
Brazilian deaf individuals. Hence, we consider that the IVS
1 + 1 G > A study should be included in molecular analysis of
nonsyndromic deafness in the Brazilian population.
The GJB2 point mutation, p.K168R (HGMD Accession No.
CM071795), was found in three monoallelic patients with
severe profound deafness. In these patients, the analysis of the
entire coding region of the Cx26 gene did not reveal the
presence of a second mutation in the other allele. The p.K168R
mutation is caused by A > G change in the nucleotide 503 of
the gene. The lysine amino acid at position 168, in EC2, is
conserved across multiple species, including human. The
atomic structure of the Cx26 GJ channel (PDB code 2ZW3)
provided evidence for the role of E2 in the docking of hemi-
channels. In E2, Lys 168, Asp 179, and the main-chain car-
bonyl groups of Thr 177 and Asn 176 form hydrogen bonds
and salt bridges with the opposite protomer (Maeda et al.,
2009). Additional studies are needed to elucidate the effect of
K168R mutation on structural change of E2 domains and its
consequent involvement in hearing loss. Genotyping analysis
revealed that the K168R was inherited from the normal
hearing mothers in two studied patients. Therefore, this var-
iant is unlikely to have a dominant effect. The p.K168R was
not found in our normal controls. These results may imply a
pathogenic mutation in another part of the DFNB1 locus as-
sociated with K168R in affected patients or that the p.K168R
mutation is a benign polymorphism.
In the GJB3 gene, currently > 10 different mutations have
been found in deaf patients from Chinese, Brazilian, and
Spanish populations (Lopez-Bigas et al., 2001; Alexandrino
et al., 2004; Liu et al., 2009). However, the pathogenicity of
most of these sequence alterations was not yet confirmed.
MLPA analysis did not reveal any additional deletion or du-
plication in GJB3 gene in heterozygous patients.
Our study allowed us to clarify the etiology of deafness in
13 of 46 heterozygous GJB2 patients, thus reducing the
number of unelucidated cases. The diversity of sequence
variants in our samples reflects the great heterogeneity of the
genetic hearing loss. However, most patients carrying
monoallelic mutations in GJB2 remain with genetic etiology of
deafness unclear. Our work highlights the need for develop-
ing new technologies that allow complete screening of all
deafness genes in a quick way with low cost. Analysis to
identify mutations in other parts of GJB2 (promoter, 3¢ UTR),
new rearrangements in the DFNB1 locus, or epistatic inter-
actions between GJB2 mutations and other unlinked gene(s)
may contribute to elucidation of molecular diagnosis of pa-
tients with only one mutant GJB2 allele.
The MLPA technique has proven to be a highly accurate
method to detect known deletions in GJB6 as well as the
35delG and IVS1 1 + 1 G > A mutations in GJB2 (Gürtler et al.,
2008; da Silva Costa et al., 2009; Shan et al., 2010). Many factors
can affect the MLPA results, including sample quality, arti-
facts during the experimental procedure, polymorphisms/
mutations in the probe target sequence, the quality of the
capillary electrophoresis, and the data analysis method used.
Moreover, MLPA is not a suitable method to detect unknown
point mutations. Nevertheless, MLPA is able to discriminate
known point mutations when probes are designed in such a
way that the site of the point mutation coincides with the
ligation site.
On the other hand, MLPA is a multiplex PCR method de-
signed to detect deletions/duplications of one or more exons
of the GJB2, GJB3, GJB6, and WFS1 genes simultaneously.
MLPA is a technically uncomplicated method and can be
performed in many laboratories, as it only requires a ther-
mocycler and capillary electrophoresis equipment.
Currently, a strategy for broad screening, as required for
molecular diagnostics, includes the use of several methods
leading to a more accurate genetic diagnosis of deafness.
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Gürtler N, Egenter C, Bösch N, Plasilova M (2008) Mutation
analysis of the Cx26, Cx30, and Cx31 genes in autosomal re-
cessive nonsyndromic hearing impairment. Acta Otolaryngol
128:1056–1062.
Kenneson A, Van Naarden Braun K, Boyle C (2002) GJB2 (con-
nexin 26) variants and nonsyndromic sensorineural hearing
loss: a HuGE review. Genet Med 4:258–274.
Kumar NM, Gilula NB (1996) The gap junction communication
channel. Cell 84:381–388. Review.
Liu XZ, Xia XJ, Xu LR, et al. (2000) Mutations in connexin31
underlie recessive as well as dominant nonsyndromic hearing
loss. Hum Mol Genet 9:63–67.
Liu XZ, Yuan Y, Yan D, et al. (2009) Digenic inheritance of non-
syndromic deafness caused by mutations at the gap junction
proteins Cx26 and Cx31. Hum Genet 125:53–62.
852 DA SILVA-COSTA ET AL.
Lopez-Bigas N, Olive M, Rabionet R, et al. (2001) Connexin 31
(GJB3) is expressed in the peripheral and auditory nerves and
causes neuropathy and hearing impairment. Hum Mol Genet
10:947–952.
Maeda S, Nakagawa S, Suga M, et al. (2009) Structure of the
connexin 26 gap junction channel at 3.5 A resolution. Nature
458:597–602.
Morton CC, Nance WE (2006) Newborn hearing screening—a
silent revolution. N Engl J Med 354:2151–2164.
Oliveira CA, Alexandrino F, Abe-Sandes K, et al. (2004) Fre-
quency of the 35delG mutation in the GJB2 gene in samples
of European, Asian, and African Brazilians. Hum Biol 76:
313–316.
Parra FC, Amado RC, Lambertucci JR, et al. (2003) Color and
genomic ancestry in Brazilians. Proc Natl Acad Sci USA
100:177–182.
Piatto VB, Bertollo EMG, Sartorato EL, Maniglia JV (2004) Pre-
valence of the GJB2 mutations and the del(GJB6-d13s1830)
mutation in Brazilian patients with deafness. Hear Res 196:
87–93.
Sambrook J, Fritsch EF, Maniatis T (1989) Molecuar Cloning: A
Laboratory Manual, 2nd edition. Cold Spring Harbor La-
boratory Press, Cold Spring Harbor, NY.
Scott DA, Kraft ML, Carmi R, et al. (1998) Identification
of mutations in the connexin 26 gene that cause autoso-
mal recessive nonsyndromic hearing loss. Hum Mutat 11:
387–394.
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